Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Thomas Balligand, M.D., Ph.D.

Concepts (59)

Back to Profile
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Thomas Balligand's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Thomas Balligand has written about over time.
Hydroxylysine, 1 publications between 2012 and 2012, average publication date January 2012. STAT5 Transcription Factor, 1 publications between 2016 and 2016, average publication date February 2016. Frameshift Mutation, 2 publications between 2016 and 2019, average publication date November 2017. Polycythemia, 1 publications between 2017 and 2017, average publication date December 2017. Receptors, Erythropoietin, 1 publications between 2017 and 2017, average publication date December 2017. Receptors, Cytokine, 1 publications between 2019 and 2019, average publication date January 2019. Janus Kinase 2, 3 publications between 2016 and 2023, average publication date June 2019. Signal Transduction, 3 publications between 2016 and 2023, average publication date July 2019. Exons, 1 publications between 2019 and 2019, average publication date August 2019. Heart, 1 publications between 2019 and 2019, average publication date August 2019. Homozygote, 1 publications between 2019 and 2019, average publication date August 2019. Primary Myelofibrosis, 1 publications between 2019 and 2019, average publication date August 2019. Thrombocythemia, Essential, 1 publications between 2019 and 2019, average publication date August 2019. Thrombocytosis, 1 publications between 2019 and 2019, average publication date August 2019. Calreticulin, 5 publications between 2016 and 2023, average publication date November 2019. Receptors, Thrombopoietin, 5 publications between 2016 and 2023, average publication date December 2019. Hematoxylin, 1 publications between 2021 and 2021, average publication date April 2021. Myeloproliferative Disorders, 2 publications between 2021 and 2023, average publication date March 2022. Zanamivir, 1 publications between 2023 and 2023, average publication date June 2023.

To see the data from this visualization as text, click here.
Balligand's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (59)
Explore
_
Co-Authors (1)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
© 2024 President and Fellows of Harvard College
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.